That's where Intuitive Surgical (NASDAQ: ISRG), the pioneer in robotic surgery, comes in. Its da Vinci Surgical System gained U.S. Food and Drug Administration approval almost 20 years ago in 2000, and the company is now a giant (currently valued at $60 billion) and still leading the charge in the industry by helping surgeons provide better outcomes for patients, not replacing them.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,